Grantham, Mayo, Van Otterloo & Co (GMO)’s Gildan GIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-21,585
Closed -$1.2M 685
2026
Q1
$1.2M Buy
21,585
+10,900
+102% +$705K ﹤0.01% 492
2025
Q4
$669K Buy
+10,685
New +$635K ﹤0.01% 554
2025
Q3
Sell
-101,758
Closed -$5.01M 628
2025
Q2
$5.01M Sell
101,758
-54,686
-35% -$2.51M 0.02% 296
2025
Q1
$6.92M Buy
156,444
+113,348
+263% +$5.63M 0.02% 275
2024
Q4
$2.03M Buy
+43,096
New +$2.08M 0.01% 375
2023
Q4
Sell
-7,680
Closed -$215K 535
2023
Q3
$215K Buy
+7,680
New +$230K ﹤0.01% 548
2017
Q1
Sell
-393,134
Closed -$9.99M 605
2016
Q4
$9.99M Hold
393,134
0.05% 183
2016
Q3
$11M Sell
393,134
-205,200
-34% -$6.06M 0.05% 197
2016
Q2
$17.4M Hold
598,334
0.07% 180
2016
Q1
$18.3M Buy
598,334
+13,700
+2% +$364K 0.07% 186
2015
Q4
$16.6M Hold
584,634
0.06% 164
2015
Q3
$17.6M Buy
584,634
+600
+0.1% +$19.2K 0.06% 153
2015
Q2
$19.4M Hold
584,034
0.06% 139
2015
Q1
$17.2M Sell
584,034
-314,312
-35% -$9.19M 0.05% 145
2014
Q4
$25.5M Buy
898,346
+15,600
+2% +$444K 0.07% 123
2014
Q3
$24.2M Hold
882,746
0.06% 135
2014
Q2
$26.1M Buy
882,746
+1,000
+0.1% +$26.7K 0.07% 126
2014
Q1
$22.3M Buy
881,746
+160,800
+22% +$4.14M 0.06% 140
2013
Q4
$19.2M Buy
720,946
+20,384
+3% +$498K 0.05% 150
2013
Q3
$16.3M Sell
700,562
-432,574
-38% -$9.68M 0.04% 161
2013
Q2
$22.9M Buy
+1,133,136
New +$22.9M 0.06% 121

Other funds holding GIL

Grantham, Mayo, Van Otterloo & Co (GMO)'s GIL Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Gildan (GIL) in Q2 2026, closing a stake of 21,585 shares — an estimated $1.2M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in GIL in Q2 2013 and held it in 21 quarters. The position peaked at $26.1M in Q2 2014. 459 funds tracked by Wall St. Rank hold GIL as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Gildan position as of Q2 2026 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 21,585 Gildan shares in Q2 2026, an estimated $1.2M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Gildan in Q2 2013 and held it in 21 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Gildan position peaked at $26.1M in Q2 2014.
  • 459 funds tracked by Wall St. Rank held Gildan as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.